Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease non-alcoholic fatty liver disease
Symptom C0019204|hepatocellular carcinoma
Sentences 6
PubMedID- 25694178 We review the role of liver ultrasonography (us) and related techniques as non-invasive tools in predicting metabolic derangements, liver histology, portal hypertension and cardiovascular risk as well as allowing early diagnosis and management of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease.
PubMedID- 26274335 Association of nonalcoholic fatty liver disease (nafld) with hepatocellular carcinoma (hcc) in the united states from 2004 to 2009.
PubMedID- 26202505 Value of shear wave velocity measurements for the risk assessment of hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease : hcc risk assessment by vttq.
PubMedID- 23905912 Objectives: the incidence of hepatocellular carcinoma associated with nonalcoholic fatty liver disease is increasing.
PubMedID- 25744657 Purpose: the incidence of hepatocellular carcinoma (hcc) in patients with nonalcoholic fatty liver disease (nafld) is increasing.
PubMedID- 26250831 hepatocellular carcinoma in the setting of non-cirrhotic nonalcoholic fatty liver disease and the metabolic syndrome: us experience.

Page: 1